Search results
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance· 47 minutes agoNovavax stock (NVAX) skyrocketed on Friday, gaining as much as 120% on the news French drug and...
Merit Financial Group LLC Lowers Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 1 day agoMerit Financial Group LLC lowered its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 19.1% in the 4th quarter, according to its most recent 13F filing with the SEC ...
Moderna Stock Seesaws After The FDA Throws It A Curveball
Investor's Business Daily· 4 hours agoThe FDA was due to make a decision by May 12. Moderna emphasized the FDA has not said it found any...
Positive week for Moderna, Inc. (NASDAQ:MRNA) institutional investors who lost 6.8% over the past...
Simply Wall St. via Yahoo Finance· 1 day agoKey Insights Significantly high institutional ownership implies Moderna's stock price is sensitive...
Moderna’s mRNA dreams meet reality with first post-COVID shot - The Boston Globe
The Boston Globe· 21 hours agoModerna’s stock dropped 45 percent last year, making it the worst-performing large biotech in the...
Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick...
Benzinga· 43 minutes agoEditor’s note: This story has been updated to correct an error in the price action of Charter...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 4 hours ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
Moderna Stock Slips as FDA Delays RSV Vaccine Approval
Investopedia· 11 hours agoModerna (MRNA) shares lost ground in intraday trading Friday as the biotech’s effort to move beyond...
Novavax, Nvidia, Sweetgreen rise premarket; Moderna, Yelp fall By Investing.com
Investing.com· 7 hours agoNovavax, Nvidia, Sweetgreen rise premarket; Moderna, Yelp fall
Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
Market Watch· 6 hours agoModerna Inc.’s stock fell 2.6% Friday, after the company said the Food and Drug Administration will...